Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared an article by Ludwige Abancourt, et al. on X:
“SBRT: A powerful option for inoperable RCC!
With 96% local control at 5 years, SBRT offers effective, non-invasive treatment while preserving renal function.”
Results of Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma in a Large Multicenter Series.
Authors: Ludwige Abancourt, et al.
